Bioxcel TherapeuticsBTAIQ

13F holders, Q3 2024 (September 30)
50holders −24
4new positions
28sold out
2famous investors
$0.61avg. 13F price*

At the end of Q3 2024, 50 institutions reported holding Bioxcel Therapeutics Inc. (BTAIQ) in their 13F filings, down 24 from Q2 2024. 4 opened new positions and 28 sold out. The largest holders were Vanguard Group Inc. ($733K), BlackRock, Inc. ($221K) and Geode Capital Management, LLC ($182K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Bioxcel Therapeutics Inc.
CUSIP
09075P105
Latest filing quarter
Q4 2024

History

Number of 13F holders

020406080 Q1 2024: 74Q1 2024Q2 2024: 74Q2 2024Q3 2024: 50Q3 2024Q4 2024: 49Q4 2024

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions4$99K
Exits28$7.8M

All 13F filers, Q2 2024 → Q3 2024: 496,000 shares bought and 7,093,579 shares sold, net −6,597,579 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 50 holders

Vanguard Group Inc. 0.00% Add +23.8% 1,201,377 $733K
BlackRock, Inc. 0.00% — 362,486 $221K
Geode Capital Management, LLC 0.00% Add +11.7% 298,043 $182K
Wells Fargo & Company 0.00% Add +38.4% 185,058 $113K
Renaissance Technologies 0.00% New 129,869 $79K
Millennium Management 0.00% Add +4.9% 128,773 $79K
Bank of America Corp. 0.00% Add +14.0% 83,701 $51K
State Street Corp. 0.00% Reduce -38.2% 77,149 $47K
Jane Street Group, LLC 0.00% Reduce -60.6% 49,317 $30K
BNP Paribas Financial Markets 0.00% Reduce -83.8% 44,381 $27K
Arete Wealth Advisors, LLC 0.00% Reduce -6.9% 40,500 $25K
Northern Trust Corp. 0.00% Reduce -79.1% 40,749 $25K
Morgan Stanley 0.00% Reduce -65.2% 40,614 $25K
Hennion & Walsh Asset Management, Inc. 0.00% Reduce -1.2% 40,099 $24K
Diversify Wealth Management, LLC 0.00% No change 40,000 $23K
Cambridge Investment Research Advisors, Inc. 0.00% No change 38,050 $23K
Susquehanna International Group, LLP 0.00% Reduce -80.3% 34,207 $21K
Group One Trading LLC 0.00% New 30,162 $18K
Commonwealth Equity Services, LLC 0.00% Add +0.8% 25,600 $16K
Squarepoint Ops LLC 0.00% Reduce -30.8% 23,710 $14K
US Bancorp \de 0.00% Reduce -2.4% 18,033 $11K
LPL Financial LLC 0.00% Reduce -4.7% 17,544 $11K
DAVENPORT & Co LLC 0.00% Reduce -20.5% 16,855 $10K
Point72 Asia (Singapore) Pte. Ltd. 0.00% Reduce -49.9% 15,186 $9K
UBS Group AG 0.00% Reduce -74.8% 13,228 $8K
SeaCrest Wealth Management, LLC 0.00% Reduce -21.6% 12,350 $8K
Tocqueville Asset Management L.P. 0.00% Reduce -72.8% 11,900 $7K
Tower Research Capital LLC (TRC) 0.00% Reduce -8.9% 10,999 $7K
Truist Financial Corp. 0.00% No change 10,879 $7K
XTX Topco Ltd 0.00% Reduce -77.0% 10,710 $7K
Apollon Wealth Management, LLC 0.00% Reduce -2.4% 10,170 $6K
Osaic Holdings, Inc. 0.00% Add +83.6% 8,500 $5K
Zurcher Kantonalbank (Zurich Cantonalbank) 0.00% Reduce -8.4% 6,028 $4K
Catalyst Funds Management Pty Ltd 0.00% No change 5,200 $3K
Federated Hermes, Inc. 0.00% Reduce -90.4% 4,819 $3K
AllSquare Wealth Management LLC 0.00% No change 4,527 $3K
Washington Trust Advisors, Inc. 0.00% No change 2,572 $2K
National Bank of Canada 0.00% Reduce -8.7% 2,375 $1K
Parkside Financial Bank & Trust 0.00% New 1,800 $1K
Simplex Trading, LLC 0.00% Reduce -90.4% 3,113 $1K
JPMorgan Chase & Co. 0.00% No change 749 $457
Toth Financial Advisory Corp. 0.00% No change 500 $305
NewEdge Advisors, LLC 0.00% No change 500 $305
Northwestern Mutual Wealth Management Co. 0.00% Reduce -3.7% 340 $207
Federation des caisses Desjardins du Quebec 0.00% No change 113 $69
Barclays PLC 0.00% Reduce -35.8% 88 $54
Point72 (DIFC) Ltd 0.00% Reduce -99.8% 31 $19
Citigroup Inc. 0.00% Reduce -100.0% 3 $2
Hantz Financial Services, Inc. 0.00% No change 50 $0
Tsfg, LLC 0.00% New 150 $0

"% of holder's portfolio" is BTAIQ's weight in each manager's 13F, not the share of Bioxcel Therapeutics Inc. the manager owns.